PRESENTATION

Q3 2026 — Presentation

Q3 2026PDF · 19 pages3.6 MB
Investor Presentation
Q3 2026
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 1 of 19 --

Cautionary note on forward-looking statements
This presentation contains “forward-looking
statements” as defined in the Private Securities
Litigation Reform Act of 1995 regarding, among other
things: future operating and financial performance,
product development, and market position and
business strategy. The reader is cautioned not to rely
on these forward-looking statements. They are based
on current expectations of future events. If underlying
assumptions prove inaccurate or known or unknown
risks or uncertainties materialize, actual results could
vary materially from the expectations and projections
of Intuitive Surgical, Inc. Risks and uncertainties
include, but are not limited to: macroeconomic
factors, which could have a materially adverse impact
on our business, financial condition, or results of
operation; reliance on sole- and single-source
suppliers and inability to purchase at acceptable
prices a sufficient supply of materials, parts, and
components; public health crises or epidemic
diseases; litigation, investigations, or other legal
proceedings; the highly competitive nature of our
industry, including customers’ preference for
competitors’ products or services; market acceptance
of our products; inability of hospitals to obtain
coverage and reimbursement for procedures using
our products or insufficient reimbursement to cover
the costs of purchasing our products; defects in or
performance problems of our products, which may
result in recalls; significant, uninsured losses; the loss
of key personnel or inability to attract and retain other
personnel; negative publicity concerning our products
or company; and long and variable capital sales cycles
and seasonality in our business. A further list and
descriptions of these risks, uncertainties, and other
factors can be found in Intuitive’s Annual Report on
Form 10-K, including in the sections captioned
“Cautionary Note Regarding Forward-Looking
Statements” and “Item 1A. Risk Factors,” and in
Intuitive’s subsequent Quarterly Reports on Form 10-Q
and other filings with the U.S. Securities and Exchange
Commission. Copies of these filings are available at
www.sec.gov, isrg.intuitive.com, and on request from
Intuitive. Any forward-looking statements in this
presentation speak only as of the date of this
presentation. Intuitive does not undertake to update
any forward-looking statements as a result of new
information or future events or developments. Some
products discussed in this presentation may not be
available without regulatory clearance. Please check
with your local regulatory contact for current status.
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 2 of 19 --

Our mission
We believe that minimally invasive care is life-
enhancing care. Through ingenuity and
intelligent technology, we expand the potential
of physicians to heal without constraints.
Our vision
We envision a future of care that is less invasive
and profoundly better, where diseases are
identified early and treated quickly so patients
can get back to what matters most.
Purpose
Value
Innovative
Transformative
Commitment
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 3 of 19 --

Length of stay
Consistency of outcomes
Surgical site infections
Complications
Readmission
Recovery
Conversions
Outpatient vs. inpatient
Ecosystem support
Ergonomics
OR / staffing efficiencies
Analytics
Training
Total clinical cost
Direct costs
Clinical variation
Enablement of MIS
reproducibility
Access to technology
and innovations
Education and
empowerment
Improve clinical
outcomes
Enhance patient
experience
Improve care
team experience
Lower total
cost of care
Expand access
to care
Where we are focused with our customers
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 4 of 19 --

Source: Intuitive 2025 earnings; 1. As of Dec. 2025. Procedures performed using Intuitive systems includes da Vinci and Ion; 2. As of Nov. 2025.
3.2M+
Procedures performed on
Intuitive systems in 2025
20.4M+
Procedures performed on
Intuitive systems to date 1
1,900+
Intuitive systems
placed in 2025
12,000+
Intuitive systems in
hospitals globally 1
3.0M+
Multiport
55K+
Single port
140K+
Ion
19.9M+
Multiport
130K+
Single port
325K+
Ion
1,610+
Multiport
100+
Single port
190+
Ion
10,720+
Multiport
370+
Single port
990+
Ion
4,000+
Peer-reviewed articles
published in 20252
48,000+
Peer-reviewed articles
published to date 2
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 5 of 19 --

Worldwide capital trends
200
400
600
800
1,000
1,200
1,400
1,600
1,800
2,000
2020 2021 2022 2023 2024 2025
System placements
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
10,000
11,000
12,000
2020 2021 2022 2023 2024 2025
Installed base
Greenfield/Incremental Trade-in Rest-of-world	Asia	United States Europe
2022	2021
+12%
YoY
6
Source: Intuitive 2025 earnings.
*da Vinci only
2023 2024	2022	2021 2023 2024 2020	2020 2025 2025
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 6 of 19 --

+21%
YoY
$1,000
$2,000
$3,000
$4,000
$5,000
$6,000
$7,000
$8,000
$9,000
$10,000
$11,000
2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue trend
(USD, in millions)
Non-recurring	Recurring
79%
2018 2019 2020 2021 2022 2023	2017
71% 71% 72% 77%
75%
83%
7
Source: Intuitive 2025 earnings; 1. Ranges listed are approximate, not all prices will fall within the range.
84%
2024
Instruments and accessories1
$900 – $3,700 per da Vinci procedure
Services1
$95K – $225K per year for
da Vinci Surgical Systems
Operational leases1
Fixed-payment or usage-based
System sale or sales-type lease1
$0.6M – $3.1M per da Vinci
Surgical System
84%
2025
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 7 of 19 --

Da Vinci
platforms
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 8 of 19 --

Da Vinci Multi-port
Source: Intuitive 2025 earnings.
2020 2021 2022 2023 2024 2025
Procedures
17%
YoY Growth
1.2M+
3.0M+
Installed base
12%
YoY Growth
2020 2021 2022 2023 2024 2025
10.7K+
5.9K+
Utilization
3%
YoY Growth
2020 2021 2022 2023 2024 2025
210+
300+
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 9 of 19 --

A strong
da Vinci 5
launch
with clearances
in the U.S., Korea,
Japan, and Europe
Source: Intuitive 2025 earnings. As of Dec. 2025.
*Utilization calculated as Q4 2025 estimate in the US.
270,000+
Procedures performed to date
1,200+
Systems installed globally
10,400+
Surgeons using da Vinci 5
11%
Higher utilization than Xi*
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 10 of 19 --

Da Vinci SP
Source: Intuitive 2025 earnings.
2020 2021 2022 2023 2024 2025
Procedures
87%
YoY Growth
5K+
55K+
Installed base
39%
YoY Growth
2020 2021 2022 2023 2024 2025
370+
60+
Utilization
29%
YoY Growth
2020 2021 2022 2023 2024 2025
110+
180+
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 11 of 19 --

Ion
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 12 of 19 --

Installed base
24%
YoY Growth
2020 2021 2022 2023 2024 2025
990+
30+
Ion
Source: Intuitive 2025 earnings.
2020 2021 2022 2023 2024 2025
Procedures
51%
YoY Growth
1K+
140K+
Utilization
9%
YoY Growth
2020 2021 2022 2023 2024 2025
80+
160+
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 13 of 19 --

Q3’26 Results
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 14 of 19 --

14%
Da Vinci Procedure growth Y/Y
12%
Da Vinci Installed base growth Y/Y
546
Da Vinci systems placed
Q3 2026 Results
$3.05
Billion in revenue (22% Y/Y)
69.9%
Non-GAAP gross margin
$3.00
Non-GAAP EPS
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 15 of 19 --

Da Vinci System Installed Base
16
12,094
Worldwide as of
September 30, 2026
6,807
United States
2,436
Europe
2,176
Asia
675
Rest of World
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 16 of 19 --

04
Innovation to reach
more patients
Advance early-stage R&D programs for
new disease states; expand line of sight.
2026 priorities
Accelerate access to
and quality of minimally
invasive care
01
Platform growth
Global expansion of da Vinci 5, SP, and
Ion. Follow-on digital feature releases
and ecosystem enhancements.
02
Procedure adoption
Focus procedure growth by country
through training, commercial activities,
and market access efforts.
03
Quality and manufacturing
Continued focus on product quality,
building industrial scale, and optimizing
manufacturing operations.
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 17 of 19 --

Corporate Impact
Outcomes-focused innovation to enhance physician and care
team performance, efficiency, and to improve patient outcomes
are at the core of what Intuitive does as a business. It is also
a vital alignment for our environmental sustainability, social
responsibility, and governance transparency work.
View 2025 Corporate Impact Report on our website ›
© 2026 Intuitive Surgical Operations, Inc. All rights reserved.

-- 18 of 19 --



-- 19 of 19 --